Micromate™ is now the first needle-based intervention robot available for sale in the United States that is compatible with both fluoroscopy and computed tomography (CT).
Austria-based Interventional Systems has decided to spin-off its validated technology for interventional radiology and oncology into the endourology space.
Learn more about the recent changes in our company.
The 2022 Year in Review is here: let’s take some time to look back on some of our proudest achievements of the year.
The latest version of the miniature robotic system was first used in a series of CT-guided percutaneous biopsies of the lung, spleen, and bone.
The new subscription service is the first to offer a full-fledged medical robot for percutaneous interventions for an affordable, fixed monthly fee.
Interventional Systems finished the implementation of the IraSME project “E-GantryMate: Compact MRI compatible device for MRI guided percutaneous needle interventions”.
Interventional Systems is proud to announce the signature of a strategic collaboration agreement with the Johns Hopkins University’s Whiting School of Engineering for the development of novel solutions to enhance the accuracy of robotic-assisted percutaneous procedures.
Interventional Systems announced the newest addition to Micromate™’s product suite: a planning and navigation station that will make the needle-based intervention miniature robot available for use with CT scanners.
It’s time to wrap up 2021 and have a close look into what’s coming up for 2022!
The miniature medical intervention robot will bring ease of use and high accuracy to the Chinese operating rooms in a partnership with the innovative Chinese
Interventional Systems announced Micromate™, the world’s smallest robot for percutaneous procedures, received its FDA 510(k) clearance, allowing the robotics company to operate in the USA.
